CUVIS-joint, the artificial articular surgical robot developed by CUREXO, receives the EEA CE mark

Saturday, March 27, 2021

On the 25th, medical robot company CUREXO, Inc. (KOSDAQ: 060280) announced that the company-developed CUVIS-joint artificial joint surgical robot received the EEA CE mark.

CUVIS-joint was MFDS certified in June last year and was provided to national general hospitals, orthopedic hospitals, and even Meril Life Sciences Pvt. Ltd., India.

In early March, Sakra World Hospital carried out 100 successful total knee replacement surgeries using the Meril-CUVIS joint robotics system and is conducting 10 operations weekly. In addition, followed by Sakra World Hospital, SAI hospital (second in India ) is in readiness for operations as CUVIS-joint will be supplied.

CUREXO, with the CE mark, will be able to expand its market throughout Europe, Australia and parts of Asia as it has done in the previous year in the domestic and Indian markets. They have their eyes set on obtaining FDA approval in order to further expand their global market.

CEO Jaejun Lee said, "We are pleased to see that we were approved for CE marking earlier than we expected. We expected the approval to take place in the second quarter of the year. We plan to promote partnerships with implant and medical companies. in Europe and proceed to the signing of agreements. Furthermore, we expect a positive result for our expansion in the global market in 2021 with our early approval."

Latest Issue
Get instant
access to our latest e-book
Sanofi UpperEdge - Healthcare ERP Transformation Medical Manufacturing Asia 2022 Medical Fair Asia 2022